MERRIMACK PHARMACEUTICALS INC MACK Income Statement

Merrimack pharmaceuticals inc (MACK)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating expenses:
License and collaboration revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaboration revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	91,285	102,847	94,104	92,296	76,674	55,528	46,165	47,786	54,154	58,621	52,232	48,921	47,307	44,566	39,098	34,215	0	0	0
Research and development expenses
-	11,100	21,331	34,290	43,229	49,974	52,103	52,742	58,815	67,314	80,575	95,224	103,168	109,565	88,729	98,245	113,356	121,033	111,807	117,676	108,665	103,310	137,806	131,804	140,474	147,139	151,648	144,903	131,196	125,858	118,823	111,851	114,280	100,630	0	0	0
General and administrative expenses
14,421	16,169	17,999	17,430	15,014	15,601	16,214	15,803	27,088	28,452	0	0	0	-	0	0	-	-	-	-	-	18,766	0	0	0	-	19,332	18,494	17,009	15,805	14,865	13,859	15,081	14,454	0	0	0
Gain on sale of assets
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on deconsolidation of Silver Creek Pharmaceuticals, Inc.
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of assets
-	-	-	0	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating (income) expenses
12,111	22,359	34,420	50,310	58,243	65,575	68,317	68,545	85,903	95,766	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55,058	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	147,327	96,164	115,379	134,667	145,081	146,793	143,801	130,396	122,076	166,056	157,109	162,953	168,326	170,980	163,397	148,205	141,663	133,688	125,710	129,361	115,084	0	0	0
Income (loss) from operations
-12,111	-22,359	-34,420	-50,310	-58,243	-65,575	-68,317	-68,545	-85,903	-95,766	-120,288	-138,828	-140,112	-147,327	-164,004	-166,779	-149,509	-145,081	-55,508	-40,954	-36,292	-29,780	-89,382	-101,581	-116,788	-120,540	-116,826	-104,776	-95,973	-92,742	-86,381	-81,144	-90,263	-80,869	0	0	0
Other income and expenses:
Interest income
457	777	1,148	1,314	1,389	1,299	1,112	1,056	1,156	895	664	478	218	276	263	212	124	99	146	140	126	114	105	134	149	166	180	208	227	184	132	76	51	56	0	0	0
Interest expense
-	1,528	1,999	0	0	-	0	-	-	34,650	32,141	32,042	21,138	22,449	25,953	28,869	17,493	18,769	18,088	18,197	18,285	18,230	18,145	17,506	14,229	10,938	0	0	0	-	-	-	8	13	0	0	0
Other expense, net
-	370	-1,082	-1,320	-2,850	-3,230	-2,619	-2,313	-2,112	-1,433	-878	-562	33	-8	616	587	761	917	730	639	690	813	992	798	752	627	427	846	843	1,357	1,169	586	677	1,150	0	0	0
Total other income and expenses
78	-381	-1,945	-2,489	-2,895	-2,887	-6,229	3,682	-21,076	-22,637	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss from continuing operations before income tax benefit
-	-	-	-	-	-	0	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax benefit
-	-	-	-	-	-	0	-	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss from continuing operations
-	-	-	-	-	-	0	-	-	-76,004	-104,266	-125,788	-147,775	-156,284	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations:
Income from discontinued operations, net of tax
-	-	-	-	-	-	0	-	-	546,872	554,458	542,572	2,762	2,766	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (loss) income
-	-	-	-	-	-	-	-	-	470,868	450,192	416,784	-145,013	-153,518	-167,959	-180,070	-152,013	-147,787	-109,196	-94,848	-90,237	-83,559	-106,430	-118,155	-130,116	-130,685	-123,230	-106,787	-96,675	-91,754	-85,082	-80,486	-89,543	-79,676	0	0	0
Net loss attributable to non-controlling interest
-	-	-	-	-	-	-	-	-	-1,160	-2,338	-2,576	-2,060	-1,778	-842	-427	-342	170	631	286	228	-268	224	229	241	240	-596	-585	-529	-477	-457	-461	-493	-453	0	0	0
Net income (loss)
-6,625	-17,332	-29,537	-24,843	-33,182	-40,506	-44,513	-45,400	483,932	472,028	452,530	419,360	-142,953	-151,740	-167,117	-179,643	-151,671	-147,957	-109,827	-95,134	-90,465	-83,291	-106,654	-118,384	-130,357	-130,925	-122,634	-106,202	-96,146	-91,277	-84,625	-80,025	-89,050	-79,223	0	0	0
Net loss from continuing operations
-	-	-	-	-	-	-	-	-	-74,844	-101,928	-123,212	-145,715	-154,506	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from discontinued operations, net of tax
-	-	-	-	-	-	-	-	-	546,872	554,458	542,572	2,762	2,766	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-6,625	-17,332	-29,537	-24,843	-33,182	-40,506	-44,513	-45,400	483,932	472,028	452,530	419,360	-142,953	-151,740	-167,116	-179,642	-151,671	-147,957	-109,828	-95,135	-90,465	-83,291	-106,654	-118,384	-130,357	-130,925	-122,634	-106,202	-96,146	-91,277	-84,625	-80,025	-89,050	-79,223	0	0	0
Other comprehensive income:
Unrealized gain on marketable securities
-	9	5	1	12	-9	0	0	0	-	-	-	-	-	-2	7	13	74	43	-3	-19	-50	-27	2	12	14	81	43	0	-	0	0	-	-	-	-	-
Other comprehensive income
-	-	-	-	0	-	0	-	-	-	-	-	-	-	-2	7	13	74	43	-3	-19	-50	-27	2	12	14	81	43	0	-	0	0	-	-	-	-	-
Comprehensive income (loss)
-6,625	-17,323	-29,532	-24,842	-33,170	-40,515	-44,518	-45,401	483,920	472,028	452,532	419,359	-142,939	-151,740	-167,119	-179,636	-151,658	-147,883	-109,784	-95,137	-90,484	-83,341	-106,681	-118,382	-130,345	-130,911	-122,660	-106,158	-96,166	-91,315	-85,098	-91,009	0	-	0	0	-
Basic and dilutive net loss per common share
Net loss from continuing operations
-	-	-	-	-	-	-0.92	-	-	-0.88	-0.40	-2.18	-2.20	-9.54	-2.06	-0.41	-0.32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income from discontinued operations, net of tax
-	-	-	-	-	-	1.22	-	-	-0.04	0.64	40.80	-0.07	0.49	-0.27	0.01	-0.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) per common share - basic and diluted
0.02	0.24	-0.05	-0.71	-0.78	-0.67	0.30	-1.33	-1.33	-0.92	0.24	38.62	-2.27	-9.05	-2.33	-0.40	-0.33	-12.38	-0.38	-0.21	-0.32	-7.27	-0.27	-0.17	-0.27	-0.33	-0.39	-0.31	-0.29	1.33	-0.25	-0.22	-2.14	-	-1.81	-2.76	-
Weighted-average common shares used to compute basic and diluted net loss per common share
13,380	13,368	13,357	13,344	13,343	13,343	13,343	13,343	13,343	13,341	13,282	13,246	13,059	-205,014	12,921	126,161	116,064	-284,996	112,417	109,975	107,148	-269,804	104,871	103,809	102,888	102,472	101,155	96,170	95,879	95,173	93,724	90,581	11,846	-	11,389	11,282	-
Cash dividends paid per common share
-	-	-	-	-	-	-	-	-	-	-	10.55	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share available to common stockholders-basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.35
Net loss per share available to common stockholders-diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.35
Weighted-average common shares used in computing net loss per share available to common stockholders-basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,106
Weighted-average common shares used in computing net loss per share available to common stockholders-diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,106